MétaCan
Menu
Back to cohort
Record W3171810880 · doi:10.3390/jpm11060511

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

2021· article· en· W3171810880 on OpenAlexafffundabout
Jennifer D. Brooks, Hermann Nabi, Irene L. Andrulis, Antonis C. Antoniou, Jocelyne Chiquette, Philippe Després, Peter Devilee, Michel Dorval, Arnaud Droit, Douglas F. Easton, Andrea Eisen, Laurence Eloy, Samantha Fienberg, David E. Goldgar, Eric Hahnen, Yann Joly, Bartha Maria Knoppers, Aïsha Lofters, Jean‐Yves Masson, Nicole Mittmann, Jean‐Sébastien Paquette, Nora Pashayan, Rita K. Schmutzler, Tracy Stockley, Sean V. Tavtigian, Meghan J. Walker, Michael Wolfson, Anna M. Chiarelli, Jacques Simard

Bibliographic record

VenueJournal of Personalized Medicine · 2021
Typearticle
Languageen
FieldMedicine
TopicGlobal Cancer Incidence and Screening
Canadian institutionsWomen's College HospitalCancer Care OntarioUniversity of OttawaMcGill UniversityUniversity Health NetworkCentre intégré de santé et de services sociaux de Chaudière-AppalachesLunenfeld-Tanenbaum Research InstituteMinistère de la Santé et des Services Sociaux (Québec)Canadian Agency for Drugs and Technologies in HealthSunnybrook Health Science CentreSinai Health SystemUniversité LavalPublic Health OntarioUniversity of Toronto
FundersCentre Hospitalier Universitaire de QuébecUniversity of TorontoMcGill UniversityGénome QuébecGenome CanadaUniversité Laval
KeywordsOverdiagnosisBreast cancerMedicineContext (archaeology)Risk assessmentCancer screeningBreast cancer screeningPopulationHealth careCancer preventionRisk analysis (engineering)GynecologyCancerMammographyEnvironmental healthComputer scienceInternal medicineComputer security

Abstract

fetched live from OpenAlex

Early detection of breast cancer through screening reduces breast cancer mortality. The benefits of screening must also be considered within the context of potential harms (e.g., false positives, overdiagnosis). Furthermore, while breast cancer risk is highly variable within the population, most screening programs use age to determine eligibility. A risk-based approach is expected to improve the benefit-harm ratio of breast cancer screening programs. The PERSPECTIVE I&I (Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation) project seeks to improve personalized risk assessment to allow for a cost-effective, population-based approach to risk-based screening and determine best practices for implementation in Canada. This commentary describes the four inter-related activities that comprise the PERSPECTIVE I&I project. 1: Identification and validation of novel moderate to high-risk susceptibility genes. 2: Improvement, validation, and adaptation of a risk prediction web-tool for the Canadian context. 3: Development and piloting of a socio-ethical framework to support implementation of risk-based breast cancer screening. 4: Economic analysis to optimize the implementation of risk-based screening. Risk-based screening and prevention is expected to benefit all women, empowering them to work with their healthcare provider to make informed decisions about screening and prevention.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.042
metaresearch head score (Gemma)0.064
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.260
Threshold uncertainty score0.517

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0420.064
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0010.001
Science and technology studies0.0030.006
Scholarly communication0.0070.003
Open science0.0030.007
Research integrity0.0090.010
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.056
GPT teacher head0.437
Teacher spread0.381 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations133
Published2021
Admission routes3
Has abstractyes

Explore more

Same venueJournal of Personalized MedicineSame topicGlobal Cancer Incidence and ScreeningFrench-language works237,207